Syneos Health Inc (SYNH) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System lowered its stake in Syneos Health Inc (NASDAQ:SYNH) by 12.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 109,039 shares of the company’s stock after selling 16,059 shares during the period. California Public Employees Retirement System owned 0.11% of Syneos Health worth $4,291,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp grew its holdings in Syneos Health by 4.2% during the second quarter. Bank of New York Mellon Corp now owns 652,958 shares of the company’s stock valued at $30,623,000 after purchasing an additional 26,267 shares during the period. First Trust Advisors LP grew its holdings in Syneos Health by 57.3% during the third quarter. First Trust Advisors LP now owns 8,073 shares of the company’s stock valued at $416,000 after purchasing an additional 2,942 shares during the period. Russell Investments Group Ltd. grew its holdings in Syneos Health by 20.2% during the third quarter. Russell Investments Group Ltd. now owns 144,102 shares of the company’s stock valued at $7,428,000 after purchasing an additional 24,262 shares during the period. Wells Fargo & Company MN grew its holdings in Syneos Health by 18.5% during the third quarter. Wells Fargo & Company MN now owns 258,874 shares of the company’s stock valued at $13,345,000 after purchasing an additional 40,366 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in Syneos Health by 1,589.5% during the third quarter. JPMorgan Chase & Co. now owns 1,319,875 shares of the company’s stock valued at $68,040,000 after purchasing an additional 1,241,754 shares during the period.

In other news, CEO Alistair Macdonald sold 8,143 shares of the company’s stock in a transaction dated Wednesday, February 13th. The stock was sold at an average price of $53.00, for a total value of $431,579.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Jonathan Olefson acquired 750 shares of the company’s stock in a transaction dated Monday, December 17th. The stock was acquired at an average cost of $41.27 per share, with a total value of $30,952.50. The disclosure for this purchase can be found here. Corporate insiders own 0.57% of the company’s stock.

Several analysts have issued reports on the company. ValuEngine lowered Syneos Health from a “buy” rating to a “hold” rating in a report on Thursday, February 28th. Robert W. Baird set a $60.00 price objective on Syneos Health and gave the stock a “buy” rating in a research note on Tuesday, January 8th. Zacks Investment Research lowered Syneos Health from a “buy” rating to a “hold” rating in a research note on Saturday, January 5th. Barclays dropped their price objective on Syneos Health from $51.00 to $45.00 and set an “equal weight” rating for the company in a research note on Thursday, January 3rd. Finally, SunTrust Banks dropped their price objective on Syneos Health to $55.00 and set a “buy” rating for the company in a research note on Wednesday, December 19th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $53.44.

NASDAQ SYNH opened at $46.92 on Friday. The stock has a market capitalization of $4.29 billion, a PE ratio of 24.19, a price-to-earnings-growth ratio of 1.19 and a beta of 1.41. The company has a debt-to-equity ratio of 0.99, a current ratio of 0.97 and a quick ratio of 0.97. Syneos Health Inc has a twelve month low of $34.40 and a twelve month high of $56.34.

ILLEGAL ACTIVITY WARNING: “Syneos Health Inc (SYNH) Shares Sold by California Public Employees Retirement System” was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2019/03/17/syneos-health-inc-synh-shares-sold-by-california-public-employees-retirement-system.html.

Syneos Health Company Profile

Syneos Health, Inc operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process.

See Also: Return on Investment (ROI) Defined, Explained

Want to see what other hedge funds are holding SYNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Syneos Health Inc (NASDAQ:SYNH).

Institutional Ownership by Quarter for Syneos Health (NASDAQ:SYNH)

Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply